Precision BioSciences (DTIL) Tops Q1 EPS by 17c

Precision BioSciences (NASDAQ: DTIL) reported Q1 EPS of ($0.33), $0.17 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $16.35 million versus the consensus estimate of $7.11 million.

For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.

You May Also Be Interested In

• AI and earnings keep driving markets as focus shifts to Trump-Xi summit
• UBS Reiterates Buy Rating on Option Care Health (OPCH) Following Check-in Call Ahead of Quiet Period
• Cal-Maine Foods (CALM) PT Lowered to $80 at Stephens